A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects

Clinical trial NCT01467531 · COMPLETED

Trial details

NCT number: NCT01467531
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infections, Human Immunodeficiency Virus and Hepatitis

Start date: 2011-11-01
Primary completion: 2012-02-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.